Filibuster
发表于 2025-3-28 15:18:09
Drugs with Quinine-like Actionustomary to refer to them as derivatives of methanol and they are further classified according to their particular aromatic ring system, e.g. quinolinemethanols, phenanthrenemethanols, pyridinemethanols, etc. Since all of the arylaminoalcohols discussed in this chapter were developed in the US Army
OMIT
发表于 2025-3-28 22:20:07
http://reply.papertrans.cn/16/1586/158588/158588_42.png
社团
发表于 2025-3-29 02:26:02
http://reply.papertrans.cn/16/1586/158588/158588_43.png
神经
发表于 2025-3-29 03:46:45
4-Aminoquinolines and Mannich Bases the most part, considered only those drugs or compounds that have shown an activity sufficient to focus broad attention upon them. Because established drugs are discussed elsewhere in this volume (see Chap. 1), much of the discussion in this chapter will centre on research and development efforts t
率直
发表于 2025-3-29 08:32:51
http://reply.papertrans.cn/16/1586/158588/158588_45.png
Admonish
发表于 2025-3-29 13:07:43
http://reply.papertrans.cn/16/1586/158588/158588_46.png
PAGAN
发表于 2025-3-29 19:20:37
Miscellaneous Compounds antiplasmodial activity is claimed, but which lie outside the main antimalarial series reviewed in the other chapters of this book. Most of the compounds described either have not been suitable for evaluation in man or have been insufficiently investigated for their activity in malaria to be defini
自负的人
发表于 2025-3-29 21:08:41
http://reply.papertrans.cn/16/1586/158588/158588_48.png
conduct
发表于 2025-3-30 01:40:04
Vehicle Dynamics and Performance,ts, especially for those patients having glucose-6-phosphate dehydrogenase-deficient erythrocytes (. et al. 1962). Much research has, therefore, been pursued in the hope of developing new 8-aminoquinoline derivatives possessing a higher therapeutic index.
盘旋
发表于 2025-3-30 04:02:23
Cell Targeting of Primaquinets, especially for those patients having glucose-6-phosphate dehydrogenase-deficient erythrocytes (. et al. 1962). Much research has, therefore, been pursued in the hope of developing new 8-aminoquinoline derivatives possessing a higher therapeutic index.